As the official scientific journal of DIA, TIRS is one of the top-rated benefits DIA Members receive. It provides a unique platform for researchers, regulators, industry, patient advocacy groups, and other healthcare decision-makers from around the globe to convert biomedical and regulatory science as well as health economic findings into practical solutions that advance human health.
Gregory Daniel
Editor-in-Chief
Gregory Daniel, PhD, MPH, is the Global Head of Public Policy at Eli Lilly & Company in Washington, D.C. Greg is also on the board of directors for the Innovation in Value Initiative (IVI), adjunct associate professor at the UNC Eshelman School of Pharmacy, and Visiting Expert at the Duke-NUS Centre of Regulatory Excellence, Duke-National University of Singapore Medical School. Formerly, he was deputy center director at the Duke-Margolis Center for Health Policy as well as fellow and managing director in the Center for Health Policy at the Brookings Institution. Greg received his PhD in pharmaceutical economics, policy, and outcomes from the University of Arizona, and an MPH, MS, and BS in Pharmacy from The Ohio State University.
Editorial Board
-
Theresa Allio
Advanced Accelerator Applications -
Josephine Babiarz
Associate Professor , MCPHS University -
Greg Ball
Associate Editor
Senior Principal Biostatistician, Merck & Co., Inc. -
David R. Bristol
President, Statistical Consulting Services Inc -
Jonca Bull
Associate Editor
Vice President, Regulatory Consulting, PPD -
Joseph Cappelleri
Executive Director of Biostatistics, Pfizer Inc -
Iraj Daizadeh
Associate Editor
Pfizer, Inc. -
Richard O. Day
Associate Editor
Professor of Clinical Pharmacology; University of New South Wales, Medicine, St. Vincent's Hospital -
Joseph A DiMasi
Director, Economic Analysis and Research Associate Professor , Tufts Center for the Study of Drug Development -
Todd Durham
Durham Statistical Consulting LLC -
Kevin Haynes
Associate Editor
Director of Clinical Epidemiology, HealthCore Inc. -
Alan M Hochberg
Principal Scientific Enablement Director, F. Hoffmann- La Roche -
Lisa Kammerman
Associate Editor
Regulatory Statistics and PRO Consultant, Kammerman Consulting, LLC -
Gracie Lieberman
Associate Editor
Senior Director Regulatory Policy, Genentech, A Member of the Roche Group -
Wendy Louise Lipworth
Senior Research Fellow, Centre for Values, Ethics and the Law in Medicine, University of Sydney -
Nicole Mahoney
Associate Editor
Executive Director, Regulatory Policy and Intelligence, Novartis -
Munish Mehra
Associate Editor
Executive Director, Tigermed -
Shunsuke Ono
Associate Professor, Laboratory of Pharmaceutical Regulatory Science, The University of Tokyo -
Peter J. Pitts
President, Center for Medicine in the Public Interest (CMPI) -
Ronald Portman
Executive Director, Pediatric Development, Science and Innovation, Clinical Development & Analytics, Novartis Pharmaceuticals Corporation -
Estelle Russek-Cohen
Associate Editor
Senior Advisor, Office of Biostat, FDA -
Ramses Sadek
Professor of Biostatistics and Director GCC Biostatistics Core, Georgia Cancer Center at Augusta University -
Rick Turner
Editor Emeritus
Expert Consultant, DRT Strategies, Inc. -
Richard C. Zink
Associate Editor
Vice President, Data Management, Biostatistics, and Statistical Programming, Lexitas Pharma Services
×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!